发明授权
US07816351B2 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus
有权
5,6-二甲基噻吩并[2,3-d]嘧啶衍生物,其制备方法和包含其的药物组合物用于抗病毒
- 专利标题: 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus
- 专利标题(中): 5,6-二甲基噻吩并[2,3-d]嘧啶衍生物,其制备方法和包含其的药物组合物用于抗病毒
-
申请号: US12067246申请日: 2005-09-23
-
公开(公告)号: US07816351B2公开(公告)日: 2010-10-19
- 发明人: Cheol Kyu Han , Jeonghyeok Yoon , Nam-Doo Kim , Jin-ah Kim
- 申请人: Cheol Kyu Han , Jeonghyeok Yoon , Nam-Doo Kim , Jin-ah Kim
- 申请人地址: KR Daejeon
- 专利权人: Equispharm Co., Ltd
- 当前专利权人: Equispharm Co., Ltd
- 当前专利权人地址: KR Daejeon
- 代理机构: Lucas & Mercanti, LLP
- 国际申请: PCT/KR2005/003172 WO 20050923
- 国际公布: WO2007/035010 WO 20070329
- 主分类号: A61K31/5377
- IPC分类号: A61K31/5377 ; C07D413/14
摘要:
Disclosed herein are 5,β-dimethylthieno[2,3-d]pyrimidine derivatives useful as antiviral agents. More particularly, disclosed are 5,β-dimethylthieno[2,3-djpyrimidine derivatives represented by Formula 1, having an excellent inhibitory effect on the proliferation of hepatitis C virus (HCV), pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the prevention and treatment of hepatitis C virus (HCV), containing, as active ingredients, these compounds. The 5,6-dimethylthieno[2,3-d]pyrimidine derivatives represented by Formula 1 have an excellent effect of inhibiting the proliferation of hepatitis C virus and also have low toxicity. Thus, these compounds are available as agents for the prevention and treatment of hepatitis C.